Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Steffen Goletz

Phase I Study of Tomuzotuximab, a Glycoengineered Therapeutic Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Carcinomas

ESMO Open
Cancer ResearchOncology
2018English

What Makes Cancer Stem Cell Markers Different?

SpringerPlus
Multidisciplinary
2013English

Related publications

Monoclonal Antibody Against Epidermal Growth Factor Receptor Is Internalized Without Stimulating Receptor Phosphorylation.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1986English

Treatment of High-Grade Glioma Patients With the Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Antibody H-R3: Report From a Phase I/Ii Trial

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2006English

First-In-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-Her3 Monoclonal Antibody, in Patients With Metastatic or Advanced HER3-Positive Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2015English

Therapeutic Potential of Epidermal Growth Factor Receptor-Related Protein

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

First-In-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients With Advanced Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2013English

Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations: A Prospective Study

Biomedical Journal
Medicine
2015English

A Phase I First-In-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients With Advanced Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

Immunohistochemical Expression of the Promising Therapeutic Target (Human Epidermal Growth Factor Receptor 2/Neu) in Iraqi Patients With Medulloblastoma

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Anti-Pd-1 Monoclonal Antibody MEDI0680 in a Phase I Study of Patients With Advanced Solid Malignancies

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy